Discover trends, market shifts, and competitive outlooks for the whole exome sequencing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Projections for the CAGR of the Whole Exome Sequencing Market Size From 2025 to 2034?
The market size for whole exome sequencing has experienced significant expansion recently. The market is projected to rise from $2.82 billion in 2024 to $3.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 19.4%. This growth during the historical period can be credited to developments in genomic research, the direction towards precision medicine, diagnosis of rare diseases, applications in pharmaceutical and biotech, and reduced sequencing costs.
In the coming years, we can expect the market size of whole exome sequencing to experience a significant surge, potentially reaching “$7.29 billion by 2029 with a compound annual growth rate (CAGR) of 21.3%. The anticipated growth during the forecast period can be linked to a range of factors such as the expanded use in oncology, its incorporation in clinical diagnostics, increasing demand for genetic testing, initiatives in population genomics, and the rise of gene therapies. Notable trends projected for the forecast period include an increase in clinical utility and adoption, a decrease in sequencing costs, emphasis on data security and privacy, its integration into electronic health records, and advancements in single-cell sequencing.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Whole Exome Sequencing Market?
The surge in HIV (human immunodeficiency virus) prevalence is predicted to boost the expansion of the entire exome sequencing market. HIV is a virus that attacks the body’s immune system. Whole exome sequencing is utilized to reveal the genomic structures of viruses, which are beneficial for personalized treatment and HIV vaccine development. The Minority HIV/AIDS Fund (MHAF), a government agency based in the US, stated in August 2024 that approximately 39.9 million individuals globally were living with HIV in 2023. This figure includes 38.6 million adults and 1.4 million children, an increase from previous years. Thus, the escalating prevalence of HIV is propelling the growth of the entire exome sequencing market.
Which Key Market Segments Comprise the Whole Exome Sequencing Market and Drive Its Revenue Growth?
The whole exome sequencing market covered in this report is segmented –
1) By Product: Systems, Kits, Services
2) By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Other Technologies
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research
4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Other End-Users
Subsegments:
1) By Systems: Sequencing Systems, Data Analysis Systems
2) By Kits: Library Preparation Kits, Exome Enrichment Kits, Sequencing Kits
3) By Services: Data Analysis Services, Consulting Services, Custom Sequencing Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=10669&type=smp
Which Areas Are Leading Regions in the Whole Exome Sequencing Market Expansion Across the Globe?
North America was the largest region in the whole exome sequencing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theWhole Exome Sequencing Market Direction?
The rise of inventive diagnostic methodologies is a crucial trend becoming increasingly widespread in the whole exome sequencing industry. As a strategy to maintain their market standing, companies in this sector are focusing on introducing novel products. For instance, in February 2023, Illumina Inc., a biotech firm based in the US, introduced NovaSeqX Plus, a game-changing sequencing technology marked by an unparalleled blend of high throughput and accuracy. Among its features are improved informatics, enhanced sustainability, and cost-effective sequencing. The integrated innovations within the NovaSeq X Plus systems are capable of producing tens of thousands of whole genomes annually, thereby optimising productivity and reducing turnaround times.
View the full report here:
https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report
How Is the Whole Exome Sequencing Market Conceptually Defined?
Whole exome sequencing refers to a genomic sequencing technique in which all of the protein-coding regions in a genome are sequenced. It is used in the laboratory to identify the mutations that may be responsible for a specific disease.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10669
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
